|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
|
US6117643A
(en)
*
|
1997-11-25 |
2000-09-12 |
Ut Battelle, Llc |
Bioluminescent bioreporter integrated circuit
|
|
EP1154691A4
(en)
*
|
1999-01-05 |
2004-07-07 |
Massachusetts Eye & Ear Infirm |
TARGETED ADMINISTRATION OF REGULATED RELEASE MEDICINE TO RETINA AND CHOROID THROUGH SCLEROTIC
|
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
|
DE60040876D1
(de)
|
1999-10-21 |
2009-01-02 |
Alcon Inc |
Medikamentenzuführeinrichtung
|
|
US6416777B1
(en)
*
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
|
WO2001028473A1
(en)
|
1999-10-21 |
2001-04-26 |
Alcon Universal Ltd. |
Sub-tenon drug delivery
|
|
US6331313B1
(en)
*
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
|
US20040115268A1
(en)
*
|
2000-04-26 |
2004-06-17 |
Control Delivery Systems, Inc. |
Systemic delivery of antiviral agents
|
|
US20040208910A1
(en)
*
|
2000-04-26 |
2004-10-21 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of adrenergic agents
|
|
US20040175410A1
(en)
*
|
2000-04-26 |
2004-09-09 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
|
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
|
USRE44145E1
(en)
|
2000-07-07 |
2013-04-09 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
|
US20040170955A1
(en)
*
|
2000-09-08 |
2004-09-02 |
Wadih Arap |
Human and mouse targeting peptides identified by phage display
|
|
US7420030B2
(en)
*
|
2000-09-08 |
2008-09-02 |
The Board Of Regents Of The University Of Texas System |
Aminopeptidase A (APA) targeting peptides for the treatment of cancer
|
|
US20050074747A1
(en)
*
|
2000-09-08 |
2005-04-07 |
Wadih Arap |
Biopanning and rapid analysis of selective interactive ligands (brasil)
|
|
US7452964B2
(en)
*
|
2001-09-07 |
2008-11-18 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides against placenta and adipose tissues
|
|
IL155479A0
(en)
|
2000-11-03 |
2003-11-23 |
Control Delivery Sys Inc |
Improved device and method for treating conditions of a joint
|
|
AU3649502A
(en)
|
2000-11-29 |
2002-06-11 |
Oculex Pharm Inc |
Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
|
|
CA2434156A1
(en)
|
2000-12-29 |
2002-07-25 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices
|
|
DE60137542D1
(de)
|
2001-01-03 |
2009-03-12 |
Bausch & Lomb |
Wirkstoffabgabevorrichtungen mit verzögerter freisetzung mehrere stoffe enthaltend
|
|
US6964781B2
(en)
*
|
2001-01-03 |
2005-11-15 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with prefabricated permeable plugs
|
|
JP2004522730A
(ja)
*
|
2001-01-03 |
2004-07-29 |
ボシュ・アンド・ロム・インコーポレイテッド |
コーティングされた薬剤コアを備えた徐放薬剤送達装置
|
|
EP1847255A3
(en)
*
|
2001-01-03 |
2009-03-04 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with coated drug cores
|
|
WO2002058667A2
(en)
*
|
2001-01-26 |
2002-08-01 |
Bausch & Lomb Incorporated |
Improved process for the production of sustained release drug delivery devices
|
|
US6713081B2
(en)
*
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
|
RU2276998C2
(ru)
|
2001-05-01 |
2006-05-27 |
Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук |
Гидрогелевые композиции
|
|
US8206738B2
(en)
|
2001-05-01 |
2012-06-26 |
Corium International, Inc. |
Hydrogel compositions with an erodible backing member
|
|
US8541021B2
(en)
*
|
2001-05-01 |
2013-09-24 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions demonstrating phase separation on contact with aqueous media
|
|
US20050215727A1
(en)
|
2001-05-01 |
2005-09-29 |
Corium |
Water-absorbent adhesive compositions and associated methods of manufacture and use
|
|
US8840918B2
(en)
*
|
2001-05-01 |
2014-09-23 |
A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences |
Hydrogel compositions for tooth whitening
|
|
US20050113510A1
(en)
|
2001-05-01 |
2005-05-26 |
Feldstein Mikhail M. |
Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
|
|
CA2447302C
(en)
*
|
2001-05-01 |
2008-07-29 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Two-phase, water-absorbent bioadhesive composition
|
|
JP2004536631A
(ja)
|
2001-05-03 |
2004-12-09 |
マサチューセッツ・アイ・アンド・イア・インファーマリー |
移植可能な薬物送達デバイスおよびその使用
|
|
ATE506929T1
(de)
*
|
2001-06-12 |
2011-05-15 |
Univ Johns Hopkins Med |
Reservoirvorrichtung für die intraokulare arzneimittelabgabe
|
|
US20040176290A1
(en)
*
|
2001-07-18 |
2004-09-09 |
Renata Pasqualini |
Anti-angiogenic state in mice and humans with retinal photorecptor cell degeneration
|
|
DE60214697T2
(de)
*
|
2001-07-23 |
2007-09-13 |
Alcon Inc. |
Vorrichtung zur freisetzung eines ophthalmischen arzneimittels
|
|
PL204644B1
(pl)
|
2001-07-23 |
2010-01-29 |
Alcon |
Okulistyczne urządzenie do podawania leków
|
|
WO2003020172A1
(en)
|
2001-08-29 |
2003-03-13 |
De Carvalho Ricardo A P |
An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues
|
|
US7749528B2
(en)
*
|
2001-08-29 |
2010-07-06 |
Ricardo Azevedo Pontes De Carvalho |
Implantable and sealable medical device for unidirectional delivery of therapeutic agents to tissues
|
|
US20040048243A1
(en)
*
|
2001-09-07 |
2004-03-11 |
Wadih Arap |
Methods and compositions for in vitro targeting
|
|
US7671010B2
(en)
*
|
2002-08-30 |
2010-03-02 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
|
|
US8507445B2
(en)
*
|
2001-09-07 |
2013-08-13 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
|
|
US20030158598A1
(en)
*
|
2001-09-17 |
2003-08-21 |
Control Delivery Systems, Inc. |
System for sustained-release delivery of anti-inflammatory agents from a coated medical device
|
|
ES2277084T3
(es)
*
|
2002-01-31 |
2007-07-01 |
Disease Control Textiles Sa |
Difusor de insecticida laminado.
|
|
US20030229333A1
(en)
*
|
2002-02-22 |
2003-12-11 |
Control Delivery Systems, Inc. |
Methods for treating otic disorders
|
|
AU2003218127B2
(en)
*
|
2002-03-11 |
2007-07-12 |
Alcon, Inc. |
Implantable drug delivery system
|
|
CA2482903A1
(en)
|
2002-04-18 |
2003-10-23 |
Lynkeus Biotech Gmbh |
Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
|
|
WO2003092665A2
(en)
*
|
2002-05-02 |
2003-11-13 |
Massachusetts Eye And Ear Infirmary |
Ocular drug delivery systems and use thereof
|
|
WO2003092514A1
(en)
*
|
2002-05-02 |
2003-11-13 |
Control Delivery Systems, Inc. |
Device and method for treating conditions of a joint
|
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
|
KR20100120243A
(ko)
*
|
2002-05-07 |
2010-11-12 |
피시비다 유에스 인코포레이티드 |
약물 전달 장치를 형성하는 공정
|
|
US7442711B2
(en)
|
2002-05-17 |
2008-10-28 |
Othera Holding, Inc. |
Amelioration of the development of cataracts and other ophthalmic diseases
|
|
US20070184089A1
(en)
*
|
2002-07-15 |
2007-08-09 |
Alcon, Inc. |
Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
|
|
ES2295647T3
(es)
|
2002-07-15 |
2008-04-16 |
Alcon, Inc. |
Composiciones de implante farmaceuticas lipofilas, no polimeras, para uso intraocular.
|
|
US7148342B2
(en)
|
2002-07-24 |
2006-12-12 |
The Trustees Of The University Of Pennyslvania |
Compositions and methods for sirna inhibition of angiogenesis
|
|
US20040221855A1
(en)
*
|
2002-10-17 |
2004-11-11 |
Paul Ashton |
Methods for monitoring treatment of disease
|
|
WO2004043435A2
(en)
*
|
2002-11-13 |
2004-05-27 |
Control Delivery Systems, Inc. |
Systemic delivery of antiviral agents
|
|
CA2729967C
(en)
*
|
2002-12-13 |
2018-01-16 |
Scholl's Wellness Company Llc |
Use of a transdermal or transmucosal ingredient delivery device
|
|
CA2510296A1
(en)
*
|
2002-12-20 |
2004-07-15 |
Control Delivery Systems, Inc. |
Steroid compositions for intraocular use
|
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
|
US20040220129A1
(en)
|
2003-01-16 |
2004-11-04 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for siRNA inhibition of ICAM-1
|
|
SI1592408T1
(sl)
*
|
2003-01-24 |
2010-01-29 |
Psivida Inc |
Naprava s podaljšanim sproščanjem in postopek za okularno dajanje adrenergičnih sredstev
|
|
AR043356A1
(es)
*
|
2003-01-24 |
2005-07-27 |
Control Delivery Sys Inc |
Dispositvo de liberacion sostenida para la administracion ocular de inhibidores de la anhidrasa carbonica y uso de inhibidores de la anhidrasa carbonica para su preparacion
|
|
AR042920A1
(es)
*
|
2003-01-24 |
2005-07-06 |
Control Delivery Sys Inc |
Liberacion controlada de agentes muy solubles
|
|
US20050019400A1
(en)
*
|
2003-01-27 |
2005-01-27 |
Deveney Thomas William |
Controlled-release drug delivery system
|
|
WO2004073551A2
(en)
*
|
2003-02-18 |
2004-09-02 |
Massachusetts Eye And Ear Infirmary |
Transscleral drug delivery device and related methods
|
|
US9445901B2
(en)
*
|
2003-03-12 |
2016-09-20 |
Deger C. Tunc |
Prosthesis with sustained release analgesic
|
|
US20050261668A1
(en)
*
|
2003-03-28 |
2005-11-24 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
US7037521B2
(en)
*
|
2003-03-28 |
2006-05-02 |
Bausch & Lomb Incorporated |
Using a laser for cutting a hole in a capsule for controlled drug delivery
|
|
US7589107B2
(en)
|
2003-05-19 |
2009-09-15 |
Othera Holding, Inc. |
Amelioration of vitrectomy-induced cataracts
|
|
US7825134B2
(en)
*
|
2003-05-19 |
2010-11-02 |
Othera Holding, Inc. |
Amelioration of cataracts, macular degeneration and other ophthalmic diseases
|
|
US7862546B2
(en)
*
|
2003-06-16 |
2011-01-04 |
Ethicon Endo-Surgery, Inc. |
Subcutaneous self attaching injection port with integral moveable retention members
|
|
US8715243B2
(en)
*
|
2003-06-16 |
2014-05-06 |
Ethicon Endo-Surgery, Inc. |
Injection port applier with downward force actuation
|
|
US7850660B2
(en)
*
|
2003-12-19 |
2010-12-14 |
Ethicon Endo-Surgery, Inc. |
Implantable medical device with simultaneous attachment mechanism and method
|
|
US7561916B2
(en)
|
2005-06-24 |
2009-07-14 |
Ethicon Endo-Surgery, Inc. |
Implantable medical device with indicator
|
|
US9592258B2
(en)
|
2003-06-27 |
2017-03-14 |
DePuy Synthes Products, Inc. |
Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
|
|
US8491883B2
(en)
*
|
2003-06-27 |
2013-07-23 |
Advanced Technologies And Regenerative Medicine, Llc |
Treatment of amyotrophic lateral sclerosis using umbilical derived cells
|
|
US8518390B2
(en)
|
2003-06-27 |
2013-08-27 |
Advanced Technologies And Regenerative Medicine, Llc |
Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
|
|
US7875272B2
(en)
*
|
2003-06-27 |
2011-01-25 |
Ethicon, Incorporated |
Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
|
|
US9572840B2
(en)
|
2003-06-27 |
2017-02-21 |
DePuy Synthes Products, Inc. |
Regeneration and repair of neural tissue using postpartum-derived cells
|
|
US8790637B2
(en)
|
2003-06-27 |
2014-07-29 |
DePuy Synthes Products, LLC |
Repair and regeneration of ocular tissue using postpartum-derived cells
|
|
CA2530732C
(en)
|
2003-06-27 |
2015-03-31 |
DePuy Synthes Products, Inc. |
Regeneration and repair of neural tissue using postpartum-derived cells
|
|
US20040265356A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
US20050054586A1
(en)
*
|
2003-06-30 |
2005-03-10 |
Bartels Stephen P. |
Treatment of ophthalmic disorders
|
|
US7888546B2
(en)
*
|
2003-07-03 |
2011-02-15 |
Corium International, Inc. |
Wound dressing, ingredient delivery device and IV hold-down, and method relating to same
|
|
JP2007526019A
(ja)
*
|
2003-07-10 |
2007-09-13 |
アルコン，インコーポレイティド |
眼科用薬物送達デバイス
|
|
CN1882338A
(zh)
*
|
2003-09-18 |
2006-12-20 |
马库赛特公司 |
经巩膜递送
|
|
WO2005051234A2
(en)
*
|
2003-11-13 |
2005-06-09 |
Control Delivery Systems, Inc. |
Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin
|
|
US20050130906A1
(en)
*
|
2003-11-20 |
2005-06-16 |
Matier William L. |
Amelioration of macular degeneration and other ophthalmic diseases
|
|
US8162897B2
(en)
*
|
2003-12-19 |
2012-04-24 |
Ethicon Endo-Surgery, Inc. |
Audible and tactile feedback
|
|
US20050148948A1
(en)
*
|
2003-12-19 |
2005-07-07 |
Caputa Steven G. |
Sutureless ophthalmic drug delivery system and method
|
|
DE10360185A1
(de)
*
|
2003-12-20 |
2005-08-04 |
Max Wyssmann |
Vorrichtung zur gezielten, steuerbaren Abgabe oder zum Ansaugen einer Flüssigkeit oder einer viskosen Masse
|
|
US20050137538A1
(en)
*
|
2003-12-22 |
2005-06-23 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
US7211272B2
(en)
*
|
2003-12-22 |
2007-05-01 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
US20050136095A1
(en)
*
|
2003-12-22 |
2005-06-23 |
Brian Levy |
Drug delivery device with suture ring
|
|
US20050158365A1
(en)
|
2003-12-22 |
2005-07-21 |
David Watson |
Drug delivery device with mechanical locking mechanism
|
|
US20070053963A1
(en)
*
|
2004-01-13 |
2007-03-08 |
Hotchkiss Robert N |
Drug delivery to a joint
|
|
CA2554424A1
(en)
*
|
2004-01-26 |
2005-08-11 |
Control Delivery Systems, Inc. |
Controlled and sustained delivery of nucleic acid-based therapeutic agents
|
|
CN1929819B
(zh)
|
2004-01-30 |
2012-02-29 |
考里安国际公司 |
递送活性剂的快速溶解膜
|
|
US20060018949A1
(en)
*
|
2004-04-07 |
2006-01-26 |
Bausch & Lomb Incorporated |
Injectable biodegradable drug delivery system
|
|
US20050244469A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
KR20070026654A
(ko)
*
|
2004-05-25 |
2007-03-08 |
오쎄라 파마슈티걸즈, 인크. |
눈-선택성 드러그 및 프로드러그
|
|
EP2803357B1
(en)
|
2004-06-25 |
2020-11-18 |
The Johns-Hopkins University |
Angiogenesis inhibitors
|
|
US20060110428A1
(en)
*
|
2004-07-02 |
2006-05-25 |
Eugene Dejuan |
Methods and devices for the treatment of ocular conditions
|
|
WO2006014434A2
(en)
|
2004-07-02 |
2006-02-09 |
Eliot Lazar |
Treatment medium delivery device and methods for delivery
|
|
ES2526700T3
(es)
*
|
2004-08-05 |
2015-01-14 |
Corium International, Inc. |
Composición de adhesivo
|
|
US20060068012A1
(en)
*
|
2004-09-29 |
2006-03-30 |
Bausch & Lomb Incorporated |
Process for preparing poly (vinyl alcohol) drug delivery devices with humidity control
|
|
US20060067978A1
(en)
*
|
2004-09-29 |
2006-03-30 |
Bausch & Lomb Incorporated |
Process for preparing poly(vinyl alcohol) drug delivery devices
|
|
WO2006039459A1
(en)
*
|
2004-09-30 |
2006-04-13 |
Bausch & Lomb Incorporated |
Capsule for encasing tablets for surgical insertion into the human body
|
|
WO2006039333A1
(en)
*
|
2004-09-30 |
2006-04-13 |
Bausch & Lomb Incorporated |
Ophthalmic drug release device for multiple drug release
|
|
US20060078592A1
(en)
*
|
2004-10-12 |
2006-04-13 |
Bausch & Lomb Incorporated |
Drug delivery systems
|
|
US20070276481A1
(en)
*
|
2004-12-08 |
2007-11-29 |
Renner Steven B |
Drug delivery device
|
|
US20060134162A1
(en)
*
|
2004-12-16 |
2006-06-22 |
Larson Christopher W |
Methods for fabricating a drug delivery device
|
|
WO2006083394A2
(en)
*
|
2004-12-21 |
2006-08-10 |
Ethicon, Inc. |
Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
|
|
US20060171930A1
(en)
*
|
2004-12-21 |
2006-08-03 |
Agnieszka Seyda |
Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
|
|
US20060153815A1
(en)
*
|
2004-12-21 |
2006-07-13 |
Agnieszka Seyda |
Tissue engineering devices for the repair and regeneration of tissue
|
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
|
US20060134174A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
|
US20060134175A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Stephen Bartels |
Drug eluting pharmaceutical delivery system for treatment of ocular disease and method of use
|
|
US20060135918A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Reusable drug delivery device
|
|
CA2589041C
(en)
|
2004-12-23 |
2019-08-20 |
DePuy Synthes Products, Inc. |
Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
|
|
WO2006071802A2
(en)
|
2004-12-23 |
2006-07-06 |
Ethicon Incorporated |
Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells
|
|
WO2006086744A1
(en)
|
2005-02-09 |
2006-08-17 |
Macusight, Inc. |
Formulations for ocular treatment
|
|
US8663639B2
(en)
*
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
WO2006102378A2
(en)
*
|
2005-03-21 |
2006-09-28 |
Macusight, Inc. |
Drug delivery systems for treatment of diseases or conditions
|
|
JP2008535847A
(ja)
*
|
2005-04-08 |
2008-09-04 |
サーモディクス，インコーポレイティド |
網膜下に送達するための持続放出インプラント
|
|
WO2006127592A2
(en)
*
|
2005-05-26 |
2006-11-30 |
Othera Pharmaceuticals, Inc. |
Use of hydroxylamine derivates for inhibiting vitrectomy-induced cataracts
|
|
US7918844B2
(en)
|
2005-06-24 |
2011-04-05 |
Ethicon Endo-Surgery, Inc. |
Applier for implantable medical device
|
|
US7651483B2
(en)
*
|
2005-06-24 |
2010-01-26 |
Ethicon Endo-Surgery, Inc. |
Injection port
|
|
US20060292202A1
(en)
*
|
2005-06-27 |
2006-12-28 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
CN101267779A
(zh)
|
2005-07-27 |
2008-09-17 |
福罗里达大学研究基金会有限公司 |
使用热休克治疗眼睛疾病
|
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
|
WO2007064752A2
(en)
|
2005-11-29 |
2007-06-07 |
Smithkline Beecham Corporation |
Treatment of ocular neovascular disorders such as macular degeneration, angiod streaks, uveitis and macular edema
|
|
JP5289970B2
(ja)
*
|
2005-12-16 |
2013-09-11 |
エシコン・インコーポレイテッド |
組織適合性不適合な移植における逆免疫反応を抑制するための組成物および方法
|
|
US9125906B2
(en)
|
2005-12-28 |
2015-09-08 |
DePuy Synthes Products, Inc. |
Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
|
|
CN101437576A
(zh)
*
|
2005-12-28 |
2009-05-20 |
伊西康公司 |
使用产后衍生细胞治疗外周血管疾病
|
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
|
JP5528708B2
(ja)
|
2006-02-09 |
2014-06-25 |
参天製薬株式会社 |
安定な製剤ならびにそれらを調製および使用する方法
|
|
US20070203190A1
(en)
*
|
2006-02-22 |
2007-08-30 |
Ghanshyam Patil |
Hydroxylamines and derivatives for the inhibition of complement activation
|
|
ES2563288T3
(es)
|
2006-03-23 |
2016-03-14 |
Santen Pharmaceutical Co., Ltd |
Rapamicina en dosis bajas para el tratamiento de enfermedades relacionadas con la permeabilidad vascular
|
|
MX2008012601A
(es)
|
2006-03-31 |
2009-02-10 |
Qlt Plug Delivery Inc |
Metodos de suministro de farmaco, estructuras, y composiciones para un sistema nasolagrimal.
|
|
WO2007133758A1
(en)
*
|
2006-05-15 |
2007-11-22 |
Physical Pharmaceutica, Llc |
Composition and improved method for preparation of small particles
|
|
JP2009540011A
(ja)
*
|
2006-06-12 |
2009-11-19 |
エクセジェニックス、インク．ディー／ビー／エー オプコ ヘルス、インク． |
血管新生のｓｉＲＮＡ阻害のための組成物及び方法
|
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US8802128B2
(en)
*
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
WO2008021728A2
(en)
|
2006-08-07 |
2008-02-21 |
Bausch & Lomb Incorporated |
Treating infections and sequelae thereof with combined dissociated' glucocorticoid receptor agonists and anti-infective agents
|
|
KR20090050091A
(ko)
*
|
2006-08-31 |
2009-05-19 |
보오슈 앤드 롬 인코포레이팃드 |
녹내장 또는 그의 진행을 치료 또는 예방하기 위한 조성물 및 방법
|
|
US7872118B2
(en)
*
|
2006-09-08 |
2011-01-18 |
Opko Ophthalmics, Llc |
siRNA and methods of manufacture
|
|
US20110104159A1
(en)
*
|
2006-09-11 |
2011-05-05 |
Rohrs Brian R |
Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
|
|
PT2061444E
(pt)
*
|
2006-09-11 |
2011-07-08 |
Bausch & Lomb |
Composições e métodos de tratamento, controlo, redução, melhoramento ou prevenção de alergias
|
|
US20110105559A1
(en)
*
|
2006-09-11 |
2011-05-05 |
Rohrs Brian R |
Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy
|
|
US20080145405A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Kunzler Jay F |
Drug delivery devices
|
|
GB0713463D0
(en)
|
2007-07-11 |
2007-08-22 |
Btg Int Ltd |
Modulators of hypoxia inducible factor-1 and related uses
|
|
WO2008103613A2
(en)
|
2007-02-22 |
2008-08-28 |
Othera Holding, Inc. |
Hydroxylamine compounds and methods of their use
|
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
|
US20090042936A1
(en)
*
|
2007-08-10 |
2009-02-12 |
Ward Keith W |
Compositions and Methods for Treating or Controlling Anterior-Segment Inflammation
|
|
US20090087443A1
(en)
*
|
2007-09-27 |
2009-04-02 |
Bartels Stephen P |
Pharmacological Adjunctive Treatment Associated with Glaucoma Filtration Surgery
|
|
UA99152C2
(ru)
*
|
2007-10-05 |
2012-07-25 |
Этикон, Инкорпорейтед |
Восстановление и регенерация почечной ткани с использованием клеток, полученных с человеческой ткани пупочного канатика
|
|
US20100152646A1
(en)
*
|
2008-02-29 |
2010-06-17 |
Reshma Girijavallabhan |
Intravitreal injection device and method
|
|
EP2300095B1
(en)
|
2008-04-17 |
2015-03-11 |
Apollo Endosurgery, Inc. |
Implantable access port device and attachment system
|
|
US9023063B2
(en)
|
2008-04-17 |
2015-05-05 |
Apollo Endosurgery, Inc. |
Implantable access port device having a safety cap
|
|
US20090291073A1
(en)
*
|
2008-05-20 |
2009-11-26 |
Ward Keith W |
Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
|
|
US20100121441A1
(en)
*
|
2008-11-10 |
2010-05-13 |
Nabil Jabbour |
Surgical implant and method
|
|
CA2745832A1
(en)
|
2008-12-04 |
2010-06-10 |
Opko Ophthalmics, Llc |
Compositions and methods for selective inhibition of pro-angiogenic vegf isoforms
|
|
US20100143437A1
(en)
*
|
2008-12-09 |
2010-06-10 |
Morris Edward J |
Implantable analgesic
|
|
BRPI0923068B1
(pt)
|
2008-12-19 |
2021-05-25 |
Advanced Technologies And Regenerative Medicine, Llc |
Uso de células derivadas de tecido de cordão umbilical para tratar um paciente tendo uma doença, distúrbio ou injúria pulmonar
|
|
JP6095893B2
(ja)
*
|
2008-12-19 |
2017-03-15 |
デピュイ・シンセス・プロダクツ・インコーポレイテッド |
傷害後の神経組織の再生および修復
|
|
US10179900B2
(en)
*
|
2008-12-19 |
2019-01-15 |
DePuy Synthes Products, Inc. |
Conditioned media and methods of making a conditioned media
|
|
JP5646502B2
(ja)
*
|
2008-12-19 |
2014-12-24 |
デピュイ・シンセス・プロダクツ・エルエルシーＤｅＰｕｙ Ｓｙｎｔｈｅｓ Ｐｒｏｄｕｃｔｓ， ＬＬＣ |
神経因性疼痛を治療するための臍帯組織由来細胞
|
|
US8784879B2
(en)
*
|
2009-01-14 |
2014-07-22 |
Corium International, Inc. |
Transdermal administration of tamsulosin
|
|
CN104887389B
(zh)
|
2009-01-29 |
2017-06-23 |
弗赛特影像4股份有限公司 |
后段给药
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
WO2010093945A2
(en)
|
2009-02-13 |
2010-08-19 |
Glaukos Corporation |
Uveoscleral drug delivery implant and methods for implanting the same
|
|
ES2629003T3
(es)
*
|
2009-03-26 |
2017-08-07 |
DePuy Synthes Products, Inc. |
Células de tejido de cordón umbilical humano como tratamiento para la enfermedad de alzheimer
|
|
US20110077270A1
(en)
*
|
2009-04-21 |
2011-03-31 |
Pfeffer Bruce A |
Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure
|
|
US8632511B2
(en)
*
|
2009-05-06 |
2014-01-21 |
Alcon Research, Ltd. |
Multiple thermal sensors in a multiple processor environment for temperature control in a drug delivery device
|
|
WO2015073571A1
(en)
*
|
2013-11-15 |
2015-05-21 |
Dose Medical Corporation |
Ocular implants configured to store and release stable drug formulations
|
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
EP4289416A3
(en)
*
|
2009-05-18 |
2024-01-03 |
Dose Medical Corporation |
Drug eluting ocular implant
|
|
US12478503B2
(en)
|
2009-05-18 |
2025-11-25 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
CN102596097B
(zh)
|
2009-06-03 |
2015-05-20 |
弗赛特实验室有限责任公司 |
一种眼插入件
|
|
IN2012DN00352A
(cs)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
|
US8708979B2
(en)
|
2009-08-26 |
2014-04-29 |
Apollo Endosurgery, Inc. |
Implantable coupling device
|
|
US8506532B2
(en)
|
2009-08-26 |
2013-08-13 |
Allergan, Inc. |
System including access port and applicator tool
|
|
US8715158B2
(en)
|
2009-08-26 |
2014-05-06 |
Apollo Endosurgery, Inc. |
Implantable bottom exit port
|
|
WO2011039648A1
(en)
|
2009-09-30 |
2011-04-07 |
Glaxo Wellcome Manufacturing Pte Ltd. |
Methods of administration and treatment
|
|
JP2013512677A
(ja)
*
|
2009-12-04 |
2013-04-18 |
オプコ オプサルミクス、エルエルシー |
Ｖｅｇｆの阻害のための組成物および方法
|
|
US8177747B2
(en)
*
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
|
JP2013515741A
(ja)
*
|
2009-12-23 |
2013-05-09 |
サイヴィーダ ユーエス，インコーポレイテッド |
持続放出性送達デバイス
|
|
WO2013022801A1
(en)
|
2011-08-05 |
2013-02-14 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
|
US20110189174A1
(en)
*
|
2010-02-01 |
2011-08-04 |
Afshin Shafiee |
Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization
|
|
US8882728B2
(en)
|
2010-02-10 |
2014-11-11 |
Apollo Endosurgery, Inc. |
Implantable injection port
|
|
US20110270021A1
(en)
|
2010-04-30 |
2011-11-03 |
Allergan, Inc. |
Electronically enhanced access port for a fluid filled implant
|
|
US8992415B2
(en)
|
2010-04-30 |
2015-03-31 |
Apollo Endosurgery, Inc. |
Implantable device to protect tubing from puncture
|
|
US20110270025A1
(en)
|
2010-04-30 |
2011-11-03 |
Allergan, Inc. |
Remotely powered remotely adjustable gastric band system
|
|
EP2571526B1
(en)
*
|
2010-05-17 |
2019-03-13 |
Novaer Holdings, Inc. |
Drug delivery devices for delivery of ocular therapeutic agents
|
|
EP2585057B1
(en)
|
2010-06-25 |
2017-08-23 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Methods of treatment using sterculic acid
|
|
AU2011285548B2
(en)
|
2010-08-05 |
2014-02-06 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
|
ES2888906T3
(es)
|
2010-08-05 |
2022-01-10 |
Forsight Vision4 Inc |
Aparato inyector para la administración de fármacos
|
|
US9492315B2
(en)
|
2010-08-05 |
2016-11-15 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
US20120041258A1
(en)
|
2010-08-16 |
2012-02-16 |
Allergan, Inc. |
Implantable access port system
|
|
US20120065460A1
(en)
|
2010-09-14 |
2012-03-15 |
Greg Nitka |
Implantable access port system
|
|
US20140031769A1
(en)
|
2010-11-19 |
2014-01-30 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
US9668915B2
(en)
|
2010-11-24 |
2017-06-06 |
Dose Medical Corporation |
Drug eluting ocular implant
|
|
US9233076B2
(en)
|
2010-12-13 |
2016-01-12 |
Purdue Pharma L.P. |
Controlled release dosage forms
|
|
US8821373B2
(en)
|
2011-05-10 |
2014-09-02 |
Apollo Endosurgery, Inc. |
Directionless (orientation independent) needle injection port
|
|
US20120316199A1
(en)
|
2011-06-07 |
2012-12-13 |
Ward Keith W |
Compositions and methods for treating, controlling, reducing, or ameliorating inflammatory pain
|
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
|
WO2012174064A1
(en)
|
2011-06-14 |
2012-12-20 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
EP4249059B1
(en)
|
2011-06-28 |
2025-07-30 |
ForSight Vision4, Inc. |
An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
|
|
US8801597B2
(en)
|
2011-08-25 |
2014-08-12 |
Apollo Endosurgery, Inc. |
Implantable access port with mesh attachment rivets
|
|
US9974685B2
(en)
|
2011-08-29 |
2018-05-22 |
Mati Therapeutics |
Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
|
|
CA2846384C
(en)
|
2011-08-29 |
2020-12-15 |
Qlt Inc. |
Sustained release delivery of active agents to treat glaucoma and ocular hypertension
|
|
WO2013040426A2
(en)
|
2011-09-14 |
2013-03-21 |
Forsight Labs, Llc |
Ocular insert apparatus and methods
|
|
PT2755600T
(pt)
|
2011-09-16 |
2021-04-19 |
Forsight Vision4 Inc |
Aparelhos de troca de fluidos
|
|
CA2856703A1
(en)
|
2011-10-19 |
2013-04-25 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
US9199069B2
(en)
|
2011-10-20 |
2015-12-01 |
Apollo Endosurgery, Inc. |
Implantable injection port
|
|
US8858421B2
(en)
|
2011-11-15 |
2014-10-14 |
Apollo Endosurgery, Inc. |
Interior needle stick guard stems for tubes
|
|
US9089395B2
(en)
|
2011-11-16 |
2015-07-28 |
Appolo Endosurgery, Inc. |
Pre-loaded septum for use with an access port
|
|
AU2012346214B2
(en)
|
2011-11-30 |
2017-09-14 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
JP6322142B2
(ja)
|
2011-12-01 |
2018-05-09 |
ビカム ファーマスーティカルス，インコーポレイテッド |
オプシン結合性リガンド、組成物、及び使用方法
|
|
AU2012358810B2
(en)
|
2011-12-23 |
2018-03-15 |
DePuy Synthes Products, Inc. |
Detection of human umbilical cord tissue-derived cells
|
|
AU2013212271B2
(en)
|
2012-01-24 |
2018-01-04 |
Clarvista Medical, Inc. |
Modular intraocular lens designs and methods
|
|
US10028824B2
(en)
|
2012-01-24 |
2018-07-24 |
Clarvista Medical, Inc. |
Modular intraocular lens designs, tools and methods
|
|
US10080648B2
(en)
|
2012-01-24 |
2018-09-25 |
Clarvista Medical, Inc. |
Modular intraocular lens designs, tools and methods
|
|
US9364316B1
(en)
*
|
2012-01-24 |
2016-06-14 |
Clarvista Medical, Inc. |
Modular intraocular lens designs, tools and methods
|
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
|
KR101969594B1
(ko)
*
|
2012-05-11 |
2019-04-16 |
서강대학교산학협력단 |
안내 약물 전달 임플란트
|
|
DK2911623T3
(da)
|
2012-10-26 |
2019-10-28 |
Forsight Vision5 Inc |
Oftalmisk system til langvarig frigivelse af lægemiddel til øjet
|
|
WO2014164703A1
(en)
|
2013-03-11 |
2014-10-09 |
University Of Florida Research Foundation, Inc. |
Delivery of card protein as therapy for occular inflammation
|
|
EP2968113B8
(en)
|
2013-03-14 |
2020-10-28 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
US10517759B2
(en)
|
2013-03-15 |
2019-12-31 |
Glaukos Corporation |
Glaucoma stent and methods thereof for glaucoma treatment
|
|
EP2978393B1
(en)
|
2013-03-28 |
2023-12-27 |
ForSight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
|
WO2014179568A2
(en)
|
2013-05-02 |
2014-11-06 |
Odin Biotech |
Two-layer ocular implant
|
|
ES2864274T3
(es)
*
|
2013-11-14 |
2021-10-13 |
Eyed Pharma |
Dispositivo ocular
|
|
CA2938966C
(en)
|
2014-02-18 |
2023-03-14 |
Clarvista Medical, Inc. |
Modular intraocular lens designs, tools and methods
|
|
EP3148491B1
(en)
|
2014-05-29 |
2020-07-01 |
Glaukos Corporation |
Implants with controlled drug delivery features and manufacturing method for said implants
|
|
US9580896B2
(en)
|
2014-07-05 |
2017-02-28 |
John David Hopkins |
Apparatus and method for prolonged active agent in aqueous systems
|
|
KR102416726B1
(ko)
|
2014-07-15 |
2022-07-05 |
포사이트 비젼4, 인크. |
안구 이식물 전달 디바이스 및 방법
|
|
US9474756B2
(en)
|
2014-08-08 |
2016-10-25 |
Forsight Vision4, Inc. |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
|
US10500091B2
(en)
|
2014-11-10 |
2019-12-10 |
Forsight Vision4, Inc. |
Expandable drug delivery devices and methods of use
|
|
JP7002331B2
(ja)
|
2015-01-30 |
2022-01-20 |
クラービスタ メディカル，インコーポレイテッド |
眼内挿入用に構成された装置
|
|
EP3283004A4
(en)
|
2015-04-13 |
2018-12-05 |
Forsight Vision5, Inc. |
Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
|
|
US11925578B2
(en)
|
2015-09-02 |
2024-03-12 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
|
US11564833B2
(en)
|
2015-09-25 |
2023-01-31 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
|
US11458041B2
(en)
|
2015-10-08 |
2022-10-04 |
Ocular Therapeutix, Inc. |
Punctal plug and bioadhesives
|
|
EP3370645B1
(en)
|
2015-11-04 |
2025-12-03 |
Alcon Inc. |
Modular intraocular lens designs and tools
|
|
CA3005238A1
(en)
|
2015-11-20 |
2017-05-26 |
Forsight Vision4, Inc. |
Porous structures for extended release drug delivery devices
|
|
US11617680B2
(en)
|
2016-04-05 |
2023-04-04 |
Forsight Vision4, Inc. |
Implantable ocular drug delivery devices
|
|
EP3442479B1
(en)
|
2016-04-20 |
2026-03-04 |
Glaukos Corporation |
Bioresorbable ocular drug delivery device
|
|
US11045309B2
(en)
|
2016-05-05 |
2021-06-29 |
The Regents Of The University Of Colorado |
Intraocular lens designs for improved stability
|
|
MX2019000050A
(es)
|
2016-07-05 |
2019-05-02 |
Janssen Biotech Inc |
Tratamiento de la enfermedad vascular retinal mediante el uso de celulas progenitoras.
|
|
CN110730655B
(zh)
|
2017-06-13 |
2024-03-05 |
视点制药公司 |
可生物侵蚀的药物递送装置
|
|
US11382736B2
(en)
|
2017-06-27 |
2022-07-12 |
Alcon Inc. |
Injector, intraocular lens system, and related methods
|
|
US11103460B2
(en)
|
2017-08-07 |
2021-08-31 |
Board Of Regents, The University Of Texas System |
Fabrication methods for nanodelivery systems for long term controlled delivery of active pharmaceutical ingredients
|
|
JP7314155B2
(ja)
|
2017-11-21 |
2023-07-25 |
フォーサイト・ビジョン４・インコーポレーテッド |
膨張可能ポート送達システムのための流体交換装置及びその使用方法
|
|
US11689849B2
(en)
|
2018-05-24 |
2023-06-27 |
Nureva, Inc. |
Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
|
|
MX2020012458A
(es)
|
2018-05-24 |
2021-04-28 |
Celanese Eva Performance Polymers Llc |
Dispositivo implantable para liberacion sostenida de un compuesto de farmaco macromolecular.
|
|
CN119236191A
(zh)
|
2018-05-24 |
2025-01-03 |
塞拉尼斯伊娃高性能聚合物公司 |
用于持续释放大分子药物化合物的可植入器件
|
|
US11779739B2
(en)
*
|
2018-12-21 |
2023-10-10 |
Perfect Ip, Llc |
Drug delivery system and method
|
|
CN113710805A
(zh)
|
2019-03-04 |
2021-11-26 |
杜克大学 |
用于诊断和治疗视网膜病变的组合物和方法
|
|
BR112022015533A2
(pt)
|
2020-02-06 |
2022-09-27 |
Ocular Therapeutix Inc |
Composições e métodos para tratar doenças oculares
|
|
EP4110316A4
(en)
|
2020-02-26 |
2024-08-28 |
Case Western Reserve University |
Compositions and methods for treating misfolded protein ocular disorders
|
|
EP4706652A2
(en)
|
2020-03-25 |
2026-03-11 |
Ocular Therapeutix, Inc. |
Ocular implant containing a tyrosine kinase inhibitor
|
|
EP4142664A4
(en)
|
2020-04-27 |
2024-05-29 |
Ocular Therapeutix, Inc. |
METHODS FOR TREATING ALLERGIC CONJUNCTIVITIS
|
|
JP2023542939A
(ja)
|
2020-09-24 |
2023-10-12 |
オキュラ セラピューティクス，インコーポレイテッド |
ヒドロゲル及び活性薬剤を含む徐放性生分解性小管内挿入物
|
|
BR112023004378A2
(pt)
|
2020-09-24 |
2023-04-04 |
Ocular Therapeutix Inc |
Insertos intracanaliculares biodegradáveis de liberação sustentada que compreendem um hidrogel e uma ciclosporina
|
|
JP2024515220A
(ja)
|
2021-04-26 |
2024-04-05 |
セラニーズ・イーブイエイ・パフォーマンス・ポリマーズ・エルエルシー |
高分子薬剤化合物の持続放出用の埋め込み型デバイス
|
|
US11357620B1
(en)
|
2021-09-10 |
2022-06-14 |
California LASIK & Eye, Inc. |
Exchangeable optics and therapeutics
|
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
|
CR20250460A
(es)
|
2023-04-11 |
2025-11-19 |
Ocular Therapeutix Inc |
Implante ocular que contiene un inhibidor de la tirosina cinasa
|